Varian Medical Systems, Inc. Co (NYSE:VAR):
Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2016.
The company is so far trading up by 0.14% since yesterday’s close of $89.96.
Shares are trading at $90.09 just below the 50 day moving average of $96.83 and just above the 200 day moving average of $89.44. The 50 day moving average was down by -6.96% whereas the 200 day moving average was up $0.65 or +0.73%.
The most current P/E ratio is 21.50 and the market value is 8.44B. In the last earnings report the EPS was $4.19 and is estimated to be $4.97 for the current year with 93,699,000 shares presently outstanding. Next quarter’s EPS is forecasted to be $1.18 and the next full year EPS is anticipated to be $5.46.
A few brokerage firms have weighed in on the company of late. July 28 investment analysts at Jefferies maintained a stock rating of “Neutral” and moved up the price target to $88.00 from $85.00. On July 28 Citigroup held the stock rating at “Buy” but raised the price expectation from $81.00 to $87.00.
On January 28 Jefferies kept the company rating at “Buy” but moved down the price target to $85.00 from $90.00. Equity analyst Barrington Research began coverage of the stock giving it an initial rating of “Outperform” and setting a price target of $91.00.
RBC Capital starting coverage on VAR setting a rating of “Sector Perform” and a price target of $86.00. On November 12 analysts at Citigroup starting coverage on the stock with a rating of “Neutral” and projecting a price target of $81.00.